-
Valeant Pharmaceuticals to close Solta Medical acquisition
LAVAL, Quebec — Valeant Pharmaceuticals International on Thursday announced the expiration of the tender offer by a subsidiary of Valeant Pharmaceuticals International to purchase all of the outstanding shares of Solta Medical for $2.92 per share in cash, without interest (less any applicable withholding taxes).
The offer expired at midnight on Jan. 23, 2014.